Requirement for a standardised definition of advanced gastric cancer

Oncology Letters

Volumn 7, Issue 1, 2014, Pages 164-170

  de Sol, Angelo ^a   Trastulli, Stefano ^a   Grassi, Veronica ^a   Corsi, Alessia ^a   Barillaro, Ivan ^a   Boccolini, Andrea ^a   di Patrizi, Micol Sole ^a   di Rocco, Giorgio ^b   Santoro, Alberto ^b   Cirocchi, Roberto ^a   Boselli, Carlo ^a   Redler, Adriano ^b   Noya, Giuseppe ^a   Kong, Seong Ho ^c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

Advanced gastric cancer; Early gastric cancer; Japanese Gastroenterological Endoscopic Society; Stomach cancer

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CLINICAL EVALUATION; ECHOGRAPHY; GASTROSCOPY; GENETIC HETEROGENEITY; HUMAN; MORBIDITY; STOMACH CANCER; SURVIVAL RATE;

EID: 84888405675     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1672     Document Type: Article

References (41)

1. International Agency for Research on Cancer: GLOBOCAN 2008: Stomach cancer incidence, mortality and prevalence worldwide in 2008 summary. http://globocan.iarc.fr/factsheet.asp. Accessed February 25, 2013:
2. Coleman MP, Estève J, Damiecki P, Arslan A and Renard H: Trends in cancer incidence and mortality. IARC Sci Publ: 1-806, 1993.
3. Muir CS, Waterhouse J, Mack T, Powell J and Whelan S (eds): Cancer Incidence in Five Continents. Vol 5. IARC Scientific Publications no. 88. IARC Press, Lyon, 1987.
4. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J and Powell J (eds): Cancer Incidence in Five Continents. Vol 6. IARC Scientific Publications no. 120. IARC Press, Lyon, 1992.
5. Muñoz N and Asvall J: Time trends of intestinal and diffuse types of gastric cancer in Norway. Int J Cancer 8: 144-157, 1971.
6. Kram A, Peychewa M, Bachurska S and Domagala W: Morphometric distinction of signet-ring cell adenocarcinoma cells from foamy macrophages in gastric endoscopic biopsies. Pol J Pathol 62: 145-147, 2011.
7. Dziewulska-Bokiniec: Nowotwory narza{ogonek}dów trawiennych In: Zarys Chirurgii Onkologicznej. Kopacz A (ed). Akademia Medyczna w Gdańsku, Gdańsku, p171, 2000 (In Polish).
8. Krawczyk M (ed): Gastrointestinal Cancers. Vol 46. Wydawnictwo Lekarskie PZWL, Warsaw, pp153-155, 2001 (In Polish).
9. Godlewski J, Kuciel-Lisieska G, Licznerska G and Tenderenda M: Left-sided renal colic as a symptom of advanced stomach cancer-a case report. Wspolczesna Onkol 16: 191-193, 2012.
10. Ferlay J, Bray F, Pisani P, et al: GLOBOCAN 2000: Cancer incidence, mortality and prevalance worldwide, version 1.0. IARC Cancer Base no. 5. IARC Press, Lyon, 2001.
11. Oota K and Sobin LH: Histological typing of gastric and oesophageal tumors. In: International Histological Classification of Tumours, no. 18. World Health Organisation, Geneva, 1977.
12. Borrmann R (ed): Tumors of the stomach and duodenum. In: Handbook of Specific Pathological Anatomy and Histology. Henke F and Lubarsch O (ed). Vol 4. Springer-Verlag, Berlin, p865, 1926 (In German).
13. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
14. Ming SC: Gastric carcinoma. A pathobiological classification. Cancer 39: 2475-2485, 1977.
15. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14: 101-112, 2011.
16. Nakamura K, Ueyama T, Yao T, et al: Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer 70: 1030-1037, 1992.
17. Hirota T, Ming SC and Itabashi M (eds): Pathology of early gastric cancer. In: Gastric Cancer. Springer-Verlag, Tokyo, pp66-85, 1993.
18. Murakami T: Pathomorphological diagnosis. Definition and gross classification of early gastric cancer. Gann Monogr Cancer Res 11: 53-55, 1971.
19. Tsukuma H, Oshima A, Narahara H and Morii T: Natural history of early gastric cancer: a non-concurrent, long term, follow up study. Gut 47: 618-621, 2000.
20. Fenoglio-Preiser CM, Noffsinger AE, Belli J and Stemmermann GN: Pathologic and phenotypic features of gastric cancer. Semin Oncol 23: 292-306, 1996.
21. Ahn HS, Lee HJ, Yoo MW, et al: Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period. Br J Surg 98: 255-260, 2011.
22. Xue N, Huang P, Aronow WS, Wang Z, Nair CK, Zheng Z, Shen X, Yin Y, Huang F and Cosgrove D: Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography. Arch Med Sci 7: 457-464, 2011.
23. Ott K, Sendler A, Becker K, et al: Neoadjuvant chemotherapy with cisplatin, 5-FU and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study. Gastric Cancer 6: 159-167, 2003.
24. Scaringi S, Kianmanesh R, Sabate JM, et al: Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience. Eur J Surg Oncol 34: 1246-1252, 2008.
25. Schuhmacher CP, Fink U, Becker K, et al: Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin and cisplatinum. Closing results after 5 years of follow-up. Cancer 91: 918-927, 2001.
26. Bataille F, Rümmele P, Dietmaier W, et al: Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer. Mol Pathol 56: 286-292, 2003.
27. Carboni F, Lepiane P, Santoro R, Mancini P, Lorusso R and Santoro E: Laparoscopic surgery for gastric cancer: preliminary experience. Gastric Cancer 8: 75-77, 2005.
28. Luinetti O, Fiocca R, Villani L, Alberizzi P, Ranzani GN and Solcia E: Genetic pattern, histological structure and cellular phenotype in early and advanced gastric cancers: evidence for structure-related genetic subsets and for loss of glandular structure during progression of some tumors. Hum Pathol 29: 702-709, 1998.
29. Theuer CP, Campbell BS, Peel DJ, et al: Microsatellite instability in Japanese vs European American patients with gastric cancer. Arch Surg 137: 960-966, 2002.
30. Orditura M, De Vita F, Muto P, et al: Adjuvant chemoradiotherapy in patients with stage III or IV radically resected gastric cancer: a pilot study. Arch Surg 145: 233-238, 2010.
31. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A (eds): AJCC Cancer Staging Manual. 7th edition. Springer, New York, 2010.
32. Kim HH, Hyung WJ, Cho GS, et al: Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report-a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg 251: 417-420, 2010.
33. Han S-K: Efficacy of laparoscopic subtotal gastrectomy with D2 lymph node dissection for locally advanced gastric cancer (KLASS-02-RCT). NCT01456598. http://clinicaltrials.gov/ct2/show/NCT0145659. Verified July, 2012.
34. Chiaravalli AM, Cornaggia M, Furlan D, Capella C, Fiocca R, Tagliabue G, Klersy C and Solcia E: The role of histological investigation in prognostic evaluation of advanced gastric cancer. Analysis of histological structure and molecular changes compared with invasive pattern and stage. Virchows Arch 439: 158-169, 2011.
35. MacDonald WC, Owen DA and Le N: Chronic advanced gastric cancer: clinicopathologic analysis of survival data. Hum Pathol 39: 641-649, 2008.
36. Piso P, Werner U, Lang H, Mirena P and Klempnauer J: Proximal versus distal gastric carcinoma-what are the differences? Ann Surg Oncol 7: 520-525, 2000.
37. Zilberstein B, da Costa Martins B, Jacob CE, et al: Complications of gastrectomy with lymphadenectomy in gastric cancer. Gastric Cancer 7: 254-259, 2004.
38. Doglietto GB, Pacelli F, Caprino P, Sgadari A and Crucitti F: Surgery: independent prognostic factor in curable and far advanced gastric cancer. World J Surg 24: 459-463, 2000.
39. Piessen G, Messager M, Leteurtre E, Jean-Pierre T and Mariette C: Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg 250: 878-887, 2009.
40. Soyuer S, Soyuer I, Unal D, Ucar K, Yildiz OG and Orhan O: Prognostic significance of CD9 expression in locally advanced gastric cancer treated with surgery and adjuvant chemoradiotherapy. Pathol Res Pract 206: 607-610, 2010.
41. Wirtz HC, Müller W, Noguchi T, Scheven M, Rüschoff J, Hommel G and Gabbert HE: Prognostic value and clinopathological profile of microsatellite instability in gastric cancer. Clin Cancer Res 4:1749-1754, 1998.